Blue Ridge Cancer Center is a clinical research site located in Wytheville, Virginia, United States 24382.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Blue Ridge Cancer Center has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Oligometastatic Prostate Cancer (OMPC), Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Blue Ridge Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Blue Ridge Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Oligometastatic Prostate Cancer (OMPC), Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Blue Ridge Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.